InsidersTradesSigma
Browse the full record of transactions filed by Pine Michael Craig, Directeur du Développement Corporatif et Stratégique. Insider active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 1 reports have been published. Total volume traded: €11k. The latest transaction was disclosed on 14 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Pine Michael Craig is the Chief Corp Dev.&Strat. Officer of EyePoint Pharmaceuticals, Inc. He is responsible for the development strategy and growth initiatives of the company. His expertise is crucial for expansion and innovation.